SNY 250516 42.50P(SNY250516P42500) Stock Price Today

Clear

All

Quotes

News

Learn

Help

All

News

Announcements

No matches yet

Operations too frequent. Please try again later.

Please check network settings and try again Refresh Refresh

History record

SNY250516P42500

Watchlist

1.15
0.000.00%

15min DelayClose May 9 16:00 ET

0.00High0.00Low

Intraday

5D
Daily

News

Express News | Hawaii Says It Has Entered $700 Million Settlement With Pharmaceutical Firms Bristol-Myers Squibb and Units of French Pharmaceutical Company Sanofi - Statement
ReutersMay 9 20:09 ET
Pharma Worries Shift to Prices From Trade. Trump's Next Plan Could Sink Stocks. -- Barrons.com
Barron'sMay 9 16:51 ET
Kymera Therapeutics: 1Q Revenue Attributable to the Company's Sanofi Collaboration >KYMR
Dow JonesMay 9 07:03 ET
Sanofi (SNY.US) has reported the launch of a new antibody drug.
Caplacizumab is a nanobody targeting vWF, designed to inhibit the interaction between vWF and platelets.
Zhitong FinanceMay 8 21:12 ET
FDA to Speed up AI Rollout to Accelerate Drug Reviews
Seeking AlphaMay 8 14:53 ET
COVID Vaccine Maker Novavax Stock Soars 16% - Here's Why
BenzingaMay 8 13:31 ET

Comments

Teddy123

Mar 16 11:28

Sanofi adopts FDA-selected flu strains to ensure readiness for the 2025-26 flu season

$Sanofi (SNY.US)$
Sanofi Leads Early Flu Vaccine Preparation as CDC Reports 40M Cases This Season

Moomoo Recap US

Dec 18, 2024 05:03

Columns Tuesday, Tech Pulls Back, While Traders Await FOMC Rate | Wall Street Today

The market fell Tuesday, but stepping back, the view of tech stocks looks like a mountain range that has not peaked yet- for all of December, the Nasdaq has arched upward into all-time highs. After Monday's record, the index pulled back, following a pullback for Nvidia and Broadcom, falling after Broadcom's post-earnings stock jump finally took a pause.
Just past 4 pm ET they $S&P 500 Index (.SPX.US)$ traded down 0.39%,...

10xStockPicks

Dec 16, 2024 08:30

A.i Predicts Big Pharma Will Soon Acquire Esperion Therapeutics for $12 to $16 A share, Current Price $2.25

$Esperion Therapeutics (ESPR.US)$ Acquiring Esperion Therapeutics could be a strategic move for a big pharmaceutical company for several compelling reasons. Here are the main factors that suggest an acquisition could be beneficial for a larger player in the pharmaceutical industry:
1. Unique Market Position in Statin Alternatives
– Addressing Statin Intolerance: There are millions of statin...

Meltyy

Sep 25, 2024 19:31

See FDA PDUFA update 👀 👇

🚨 This Week’s PDUFAs:
$Heron Therapeutics (HRTX.US)$ : 🤔
⇨ ZYNRELEF® Vial Access Needle
‣ Postoperative pain
‣ PDUFA: 9/23/24 (sNDA)
$Bristol-Myers Squibb (BMY.US)$ : 🤔
⇨ KarXT (xanomeline-trospium)
‣ Schizophrenia
‣ PDUFA: 9/26/24 (NDA)
$Sanofi (SNY.US)$ $Regeneron Pharmaceuticals (REGN.US)$ : 🤔
⇨ Dupixent
‣ Chronic obstructive pulmonary disease
‣ PDUFA: 9/27/24 (sBLA)
$BeiGene (BGNE.US)$ $Merck & Co (MRK.US)$ & $Bristol-Myers Squibb (BMY.US)$ : 🤔
⇨ Tislelizumab, KEYTRUDA, OPDIVO & YER...

Meltyy

Sep 10, 2024 17:37

📅 FDA PDUFA & AdCom Update…

📣 ITRM AdCom 9/9 meeting ongoing 🚗
👀 stay tuned for updates on meeting outcomes
See 👇 for further info.
🚨 This Week’s AdCom:
$Iterum Therapeutics (ITRM.US)$ : Meeting ongoing 🤔
⇨ Sulopenem
‣ uUTI (Uncomplicated Urinary Tract Infection)
‣ AdCom: 9/9/24
🚨 Last Week’s PDUFAs:
$Travere Therapeutic (TVTX.US)$ : Approved 9/5 🎉
⇨ FILSPARI (Sparsentan)
‣ IgA nephropathy (IgAN)
‣ PDUFA: 9/5/24
$Avadel Pharmaceuticals (AVDL.US)$ : Awaiting decision 🤔
⇨ LUMRYZ (sodium oxybate)
‣...